MedPath

The usefulness of extended lymphadenectomy and molecular staging for urothelial carcinoma patients who undergo nephroureterectomy or total cystectomy

Phase 2
Conditions
rothelial carcinoma patients who undergo nephroureterectomy or total cystectomy
Registration Number
JPRN-UMIN000002519
Lead Sponsor
Department of Urology, Wakayama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

No informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
Disease specific survival Prognostic factor of molecular staging using RT-PCR method
© Copyright 2025. All Rights Reserved by MedPath